GENETEC CORPORATION downwardly revised its consolidated ordinary profit forecast for the first half from the previous forecast of ¥65 million to ¥37 million at midday on 9 November. The full-year forecast was also cut from ¥659 million to ¥649 million, with the decline in profit expected to widen.
GENETEC CORPORATION downwardly revised its consolidated ordinary profit forecast for the cumulative second quarter of the fiscal year ending March 2027 (April–September) from the previous forecast of ¥65 million to ¥37 million. The figure was ¥163 million in the same period of the previous year, implying an expected decline of more than 42%.
Following the latest first-half revision, the full-year consolidated ordinary profit forecast was also downwardly revised from ¥659 million to ¥649 million. The decline is expected to widen compared with the previous fiscal year's actual result of ¥824 million.
The article was prepared based on numerical data released by the company and calls for readers to check the earnings report PDF. Kabutan News is the source.
ISB and other companies are cited as related stocks, and attention may focus on the disclosure status of future earnings reports and any additional numerical disclosures.